Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Monocyte count and soluble markers of monocyte activation in people living with HIV and uninfected controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Acute symptoms in SARS-CoV-2 positive adolescents aged 15-18 years - Results from a Danish national cross-sectional survey study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Assessment of biomarkers in pediatric atopic dermatitis by tape strips and skin biopsies

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

"Testing Denmark" is a national, large-scale, epidemiological surveillance study of SARS-CoV-2 in the Danish population. Between September and October 2020, approximately 1.3 million people (age >15 years) were randomly invited to fill in an electronic questionnaire covering COVID-19 exposures and symptoms. The prevalence of SARS-CoV-2 antibodies was determined by point-of care rapid test (POCT) distributed to participants' home addresses. In total, 318,552 participants (24.5% invitees) completed the study and 2,519 (0.79%) were seropositive. Of the participants with a prior positive PCR test (n = 1,828), 29.1% were seropositive in the POCT. Although seropositivity increased with age, participants 61 years and over reported fewer symptoms and were tested less frequently. Seropositivity was associated with physical contact with SARS-CoV-2 infected individuals (risk ratio [RR] 7.43, 95% CI: 6.57-8.41), particular in household members (RR 17.70, 95% CI: 15.60-20.10). A greater risk of seropositivity was seen in home care workers (RR 2.09, 95% CI: 1.58-2.78) compared to office workers. A high degree of adherence with national preventive recommendations was reported (e.g., >80% use of face masks), but no difference were found between seropositive and seronegative participants. The seroprevalence result was somewhat hampered by a lower-than-expected performance of the POCT. This is likely due to a low sensitivity of the POCT or problems reading the test results, and the main findings therefore relate to risk associations. More emphasis should be placed on age, occupation, and exposure in local communities. IMPORTANCE To date, including 318,522 participants, this is the largest population-based study with broad national participation where tests and questionnaires have been sent to participants' homes. We found that more emphasis from national and local authorities toward the risk of infection should be placed on age of tested individuals, type of occupation, as well as exposure in local communities and households. To meet the challenge that broad nationwide information can be difficult to gather. This study design sets the stage for a novel way of conducting studies. Additionally, this study design can be used as a supplementary model in future general test strategy for ongoing monitoring of COVID-19 immunity in the population, both from past infection and from vaccination against SARS-CoV-2, however, with attention to the complexity of performing and reading the POCT at home.

Original languageEnglish
Article numbere01330
JournalMicrobiology spectrum
Volume9
Issue number3
Pages (from-to)1-12
Number of pages12
ISSN2165-0497
DOIs
Publication statusPublished - 22 Dec 2021

    Research areas

  • Adult, Antibodies, Viral, COVID-19/diagnosis, Denmark, Female, Humans, Immunity, Immunoglobulin G/blood, Immunoglobulin M/blood, Male, Middle Aged, Odds Ratio, Point-of-Care Testing, Population Surveillance, Prevalence, SARS-CoV-2/isolation & purification, Seroepidemiologic Studies, Surveys and Questionnaires

ID: 69835697